金吾财讯 | 康宁杰瑞制药(09966)一度涨超30%，截至发稿，涨24.91%，报7.27港元，成交额1035万港元。消息面上，康宁杰瑞制药公布，JSKN003获得国家药品监督管理局(“国家药监局”)药品审评中心突破性疗法认定，用于治疗铂耐药复发性上皮性卵巢癌(“PROC”)、原发性腹膜癌或输卵管癌，且不限人表皮生长因子受体2(“HER2”)表达水平。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.